Zymeworks

Developer of bi-specific antibodies & antibody-drug conjugates to treat cancer

placeVancouver, British Columbia, Canada calendar_todayFounded 2003 groups277 employees language zymeworks.com

Registered entities

Innovation

82 patent families (45 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace slowing. Cited 13,480 times.

YearFilings
201531
201635
201734
201826
201935
202027
202139
202229
202321
20246
20253
20261

Social engagement

Social engagement: 36.3K social following, 8 posts in the last 12 months — below the industry typical range.

Investor mix

18 investors on record; lead investors include CTI Life Sciences Fund, Fonds de solidarite FTQ, Merlin Nexus, Teralys Capital; 2 have since exited.

Investor typeCountShare
Venture capital844%
Private equity211%
Other / undisclosed844%

Hiring activity

Hires periodically

4 roles tracked across 3 of the last 12 months

20 Apr 2026 · Investment Analyst · Bellevue

11 Jan 2026 · Protein Engineering Co-op - Hands-on Biotech Research · Vancouver

5 Nov 2025 · Associate Scientist, Clinical Bioanalysis · Vancouver

6 Oct 2025 · Senior Director, Business Development · Vancouver

20 Jul 2025 · Facilities Specialist · Vancouver

Based on job postings tracked across public sources.

Coming soon